Clinical trial
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing…
NCT00293462 · Marilyn Dodd, Other · Completed
Key facts
| NCT number | NCT00293462 |
|---|---|
| Title | GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer |
| Official title | Management of Mucositis With GM-CSF (Sargramostim) Mouthwash Study Protocol |
| Lead sponsor | Marilyn Dodd, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Mucositis Oral, Radiation Toxicity, Tongue Cancer |
| Intervention type | Biological, Other |
| Interventions | sargramostim, oral salt and soda mouthwash |
| Enrollment | 91 |
| Start date | Jun 7, 2005 |
| Primary completion | Dec 31, 2009 |
| Completion | Dec 31, 2009 |
| First posted | Feb 17, 2006 |
| Last update posted | Jul 30, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: